MedTrace Logo

The Physical Exercise and Prostate Cancer Study

NCT00658229 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-10-15

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness of a four months strength training program on physical and psychological health in patients with prostate cancer during androgen deprivation therapy. It is hypothesized a beneficial effect of the intervention on physical and psychological health in patients with prostate cancer treated with androgen deprivation.

Conditions

Interventions

BEHAVIORAL

Strength training group

After 5-10 months on androgen deprivation therapy the patients in the intervention group go through a four months strength training intervention. The patients will perform three strength-training sessions per week, two under supervision of a sport instructor. Each session will consists of one-three sets of nine strength-training exercises, performed at an intensity of 6 or 10 repetitions of maximum (6-10 RM).

Sponsors & Collaborators

  • Ullevaal University Hospital

    collaborator OTHER

  • Norwegian School of Sport Sciences

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • University of Oslo

    collaborator OTHER

  • Norwegian Foundation for Health and Rehabilitation

    collaborator OTHER

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Lene Thorsen, PhD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Norway

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00658229 on ClinicalTrials.gov